Navigation Links
Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis

pregnancy (see complete product information). Adverse events reported in more than 30% of renal, cardiac or liver transplant patients receiving CellCept (in combination with cyclosporine and corticosteroids) were pain, fever, headache, asthenia, anemia, leucopenia (patients should be monitored for neutropenia; dosing should be interrupted or the dose reduced if neutropenia develops), thrombocytopenia, leukocytosis, urinary tract infection, hypertension, hypotension, peripheral edema, hypercholesteremia, hypokalemia, hyperglycemia, creatinine, BUN and cough increased, hypomagnesemia, diarrhea, constipation, nausea, vomiting, respiratory infection, dyspnea, lung disorder, pleural effusion, tremor and insomnia. Patients receiving immunosuppressant regimens are at increased risk of developing lymphomas and other malignancies, particularly of the skin.

Warning: Increased susceptibility to infection and the possible development of lymphoma may result from immunosuppression. Only physicians experienced in immunosuppressive therapy and management of renal, cardiac or hepatic transplant patients should use CellCept. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.

About Aspreva Pharmaceuticals

Aspreva is a global pharmaceutical company focused on identifying, developing, and, upon approval, commercializing evidence-based medicines for patients living with less common diseases. Aspreva common stock is traded on the NASDAQ Global Select Market under the trading symbol "ASPV" and on the Toronto Stock Exchange under the trading symbol "ASV". Learn more at http://www.aspreva.com.

About Roche

Headquartered in Basel, Switzerland, Roche is one of the world's lead
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:2/27/2015)... TORONTO , Feb. 27, 2015  Bionik Laboratories ... (the "Company"), announced today that it acquired Bionik Laboratories, ... Laboratories"), and completed the sale to qualified accredited investors ... for aggregate gross proceeds of approximately $6.2 million. Shares ... quoted on the OTC Markets under the symbol "DWTPD" ...
(Date:2/26/2015)... CLARA, Calif. , Feb. 27, 2015  Finesse expands ... Finesse Solutions announced the expansion of its ... opening is planned for mid-March and access for customers ... from the A-563, and located adjacent to the current ... by the Finesse automation engineering team and allow Finesse to ...
(Date:2/26/2015)... 2015  AbbVie (NYSE: ABBV ) ... its neuroscience and oncology development programs have been ... American Academy of Neurology annual meeting in ... The accepted abstracts feature results from studies evaluating ... treatments in AbbVie,s pipeline. Presentations will include Phase ...
Breaking Medicine Technology:Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3New Finesse Office in United Kingdom 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7
... 19, 2011 /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical Inc. ... or the "Company"), a developer, manufacturer and distributor ... ("TCM") in China, today announced that the Company,s ... Harbin Renhuang Pharmaceutical Co., Ltd ("Renhuang"), has achieved ...
... LAKE FOREST, Ill., April 19, 2011 PharMEDium Services, LLC ... issued patent number 7,918,830 for a unique safety label for ... label and a drug container (such as a syringe) with ... "Safety Device for Drug Delivery Devices and Containers," was issued ...
Cached Medicine Technology:China Botanic Pharmaceutical Provides Update on Badger Oil Sales 2China Botanic Pharmaceutical Provides Update on Badger Oil Sales 3PharMEDium Services, LLC Receives U.S. Patent 7,918,830 Entitled Safety Device for Drug Delivery Devices and Containers 2
(Date:2/28/2015)... The noted Toronto plastic surgeon Dr. ... recently featured in the January/February 2015 issue of Elevate ... Ellis was featured in an article entitled “Get the ... that Kim Cattrall has possibly undergone to maintain her ... smooth without horizontal lines or frown line creases, which ...
(Date:2/28/2015)... 28, 2015 Javon Bea Mercy ... Harvard Hospital as stroke capable by the State of ... ambulance to Mercy Harvard Hospital. , The hospital was ... their ability to treat stroke according to national standards ... transporting stroke patients to bypass hospitals not designated as ...
(Date:2/28/2015)... Plugin creators from Pixel Film Studios ... fully customizable transition pack made specifically for ... users total control over 30 transition presets built exclusively ... Film Studios. “TransFold Volume 2 gives endless possibilities to ... 2 from Pixel Film Studios brings back folding screen ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The World ... and learning materials to potential EMTs and firefighters, recently ... Bitcoins as a way to raise charitable donations for ... in Medellin, Columbia, will be held on March 29, ... run will begin at 3:30 p.m. , To ...
(Date:2/28/2015)... 2015 1Heart Caregiver Services CEO ... brand at Houston Texas Franchise Expo South and ... its executive delegates headed by Vice-President of Operations ... Training Randolph Clarito. , Franchise Expo South, sponsored ... February 4-7 and featured Franchise brands of every ...
Breaking Medicine News(10 mins):Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Bitcoin Run Is The World Scout League Commission’s Newest Project for Charity 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3
... (HealthDay News) -- Children born to mothers with postpartum depression ... hormone called oxytocin may reduce the risk, according to a ... body and has been associated with feelings of love and ... maternal depression, the researchers found. A synthetic version of the ...
... HealthDay Reporter , FRIDAY, Dec. 9 (HealthDay News) ... more form of entertainment. But for Katie Sweeney and her ... celebration. "It was absolute redemption," said Sweeney, recalling the ... Dylan, and 14-year-old son Dusty -- who has autism -- ...
... Centre for Reviews and Dissemination (CRD) at the University ... Health is a new online service provided by the ... National Library of Medicine (NLM) the world,s largest ... of selected systematic reviews and also provides information for ...
... GREENVILLE, S.C. From their fourth-floor state-of-the-art laboratory in ... University bioengineering scientists and students help keep the feet ... new facility, which opens this week, houses one of ... hip, knee and other artificial joints that were removed ...
... mobility of registered nurses (RNs) recently published in the December ... lack of mobility has serious implications for access to health ... studypart of the RN Work Project funded by the Robert ... RNs work within 40 miles of where they attended high ...
... a certain form of inherited hearing loss have ... a study by Professor Thomas Jentsch of the ... Molecular Medicine (MDC) Berlin-Buch and Professor Gary Lewin ... Spain and Nijmegen, the Netherlands. The research findings, ...
Cached Medicine News:Health News:'Love Hormone' May Buffer Kids From Mom's Depression 2Health News:Broadway Strikes an Autism-Friendly Chord 2Health News:Broadway Strikes an Autism-Friendly Chord 3Health News:Broadway Strikes an Autism-Friendly Chord 4Health News:Clemson University opens bioengineering research lab at Greenville hospital campus 2Health News:Clemson University opens bioengineering research lab at Greenville hospital campus 3Health News:New registered nurses' lack of geographic mobility has negative implications for rural health 2Health News:New registered nurses' lack of geographic mobility has negative implications for rural health 3Health News:People with DFNA2 hearing loss show increased touch sensitivity 2Health News:People with DFNA2 hearing loss show increased touch sensitivity 3
Alexander periosteal elevators....
Sedillot periosteal elevators....
Modified Freer periosteal elevator, #163, slight curve, 21 cm....
Steinhauser periosteal elevator....
Medicine Products: